×
Sanofi Revenue 2010-2024 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi revenue for the twelve months ending September 30, 2024 was
$53.031B
, a
8.22% increase
year-over-year.
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
Sanofi annual revenue for 2022 was
$47.822B
, a
3.18% increase
from 2021.
Sanofi annual revenue for 2021 was
$46.348B
, a
8.58% increase
from 2020.
View More
Sanofi Revenue 2010-2024 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
Sanofi annual revenue for 2022 was
$47.822B
, a
3.18% increase
from 2021.
Sanofi annual revenue for 2021 was
$46.348B
, a
8.58% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$692.7B
Novo Nordisk (NVO)
$460.6B
Johnson & Johnson (JNJ)
$368.4B
AbbVie (ABBV)
$294.4B
Merck (MRK)
$244.2B
Novartis AG (NVS)
$211.1B
AstraZeneca (AZN)
$197.8B
Pfizer (PFE)
$142.2B
Innoviva (INVA)
$1.2B